宋海波

Public information about Song Haibo is limited, and his writing direction can currently be understood only from the three works held in the library. All three belong to the field of medicine: Research Progress in Drug Toxicology and two volumes of the Blue Book on the Development of China's In Vitro Diagnostics Industry (Volume II, 2016, and the 2018 volume, overall Volume IV). His subjects combine academic research with industry observation: on the one hand, he addresses professional advances in drug toxicology; on the other, he helps document the development of China's in vitro diagnostics industry in the form of annual reports or blue books. Such writing typically emphasizes systematic material and practical reference value for medical researchers, industry practitioners, and relevant decision-makers. Because reliable biographical information is lacking, his nationality, dates of birth and death, education, and positions cannot be confirmed and are not speculated upon here.